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ABSTRACT  27 
BACKGROUND: Overweight and obesity is a growing health problem worldwide. 28 
The most effective strategy to reduce weight is energy restriction (ER). ER has 29 
been shown to be beneficial in disease prevention and it reduces chronic 30 
inflammation. Recent studies suggest that reducing the protein quantity of a diet 31 
contributes to the beneficial effects by ER. The organ most extensively affected 32 
during ER is white adipose tissue (WAT). 33 
OBJECTIVE: The first objective was to assess changes in gene expression 34 
between a high protein diet and a normal protein diet during ER. Secondly, the 35 
total effect of ER on changes in gene expression in WAT was assessed.  36 
METHODS: In a parallel double-blinded controlled study, overweight older 37 
participants adhered to a 25% ER diet, either combined with high protein intake  38 
(HP-ER, 1.7 g/kg per day), or with normal protein intake (NP-ER, 0.9 g/kg per 39 
day) for 12 weeks. From 10 HP-ER participants and 12 NP-ER participants 40 
subcutaneous WAT biopsies were collected before and after the diet intervention. 41 
Adipose tissue was used to isolate total RNA and to evaluate whole genome gene 42 
expression changes upon a HP-ER and NP-ER diet.  43 
RESULTS: A different gene expression response between HP-ER and NP-ER was 44 
observed for 530 genes. After NP-ER a downregulation in expression of genes 45 
linked to immune cell infiltration, adaptive immune response, and inflammasome 46 
was found whereas no such effect was found after HP-ER. HP-ER resulted in 47 
upregulation in expression of genes linked to cell cycle, GPCR signalling, olfactory 48 
signalling and nitrogen metabolism. Upon 25% ER, gene sets related to energy 49 
metabolism and immune response were decreased.  50 
CONCLUSIONS: Based on gene expression changes, we concluded that 51 
consumption of normal protein quantity compared to high protein quantity during 52 
ER has a more beneficial effect on inflammation-related gene expression in WAT. 53 
  54 
INTRODUCTION      55 
Overweight and obesity is a growing health problem worldwide1, 2 3. One of the 56 
most effective strategies to lose weight is energy restriction (ER): restriction of 57 
food intake without malnutrition4. ER is also an effective strategy to diminish 58 
age-related diseases in rodents5 and non-human primates6. Recent studies in 59 
rodents suggest that not the reduction of calories itself, but the reduction of 60 
dietary protein quantity contributes to the health benefits of ER7. In mice for 61 
example, an ad libitum low protein diet seemed to be equally beneficial for health 62 
as an energy restricted diet. Low-protein, high-carbohydrate, fed mice showed 63 
improved insulin, triglyceride, and high density lipoprotein cholesterol (HDLC) 64 
levels and improved Homeostasis Model Assessment (HOMA), similar to ER fed 65 
mice, while ad libitum fed mice did not show this improvement8. Contrary to 66 
animal studies, human studies showed less consistent findings.  67 
A meta-analysis on protein diets of periods longer than 12 weeks on health 68 
outcomes such as blood pressure, LDL, HDL and total cholesterol, triglycerides, 69 
and fasting blood glucose showed inconsistent results9. Other shorter, but also 70 
newer long-term intervention studies mainly focussed on insulin sensitivity and 71 
observed increased insulin sensitivity upon high protein ER diets10, 11 12. Based on 72 
these studies and this meta-analysis, no definitive conclusion can be drawn on 73 
the effect of protein versus other macronutrient ratios in an ER diet on markers 74 
of metabolic health. Markers of metabolic health are systemic markers reflecting 75 
the total response in the body. One of the organs largely affected by ER is the 76 
white adipose tissue (WAT). Despite the important role of visceral WAT in the 77 
pathology of obesity, the role of subcutaneous WAT is becoming more clear, 78 
especially due to the use of omics tools such as transcriptomics. It has for 79 
example been shown that subcutaneous WAT of obese individuals is 80 
characterised by hyperplasia and hypertrophy and that expression of genes 81 
involved in fat uptake and cellular differentiation are decreased in obese 82 
individuals13. This likely limited ability of subcutaneous WAT to store excess 83 
energy14 leads to the compensatory ectopically storage in organs such as liver. 84 
Nutrition may play a role in the preservation and improvement of the adequate 85 
functioning of subcutaneous WAT. Therefore subcutaneous WAT is an interesting 86 
target to study. Transcriptomics has also been used to identify differences and 87 
overlap between the different fat depots. It has been shown that deep and 88 
superficial subcutaneous WAT depots have overlapping but also site-specific gene 89 
expression profiles15. Also between epigastric and subcutaneous WAT and VAT 90 
overlap is found in expression of genes involved in inflammation, cell cycle and 91 
growth, cancer and development16. In addition, comparison between 92 
subcutaneous WAT and VAT gene expression revealed that macrophage-specific 93 
markers were visible in both17. During ER, not only the size of the adipocytes is 94 
reduced but also expression of genes involved in inflammation is decreased18-20 95 
which likely also affects other organs and the whole body metabolic health 96 
status.  97 
In this manuscript we aimed to elucidate the effects of an exchange of 98 
carbohydrates for protein during an ER diet on pathways and signalling routes in 99 
human adipose tissue by examining changes in whole genome gene expression 100 
on subcutaneous WAT. Participants of this study were older overweight healthy 101 
men and women, following either a 12-week completely controlled normal 102 
protein ER diet (NP-ER), or a high-protein ER diet (HP-ER), in which 103 
carbohydrates of the NP-ER diet were partly replaced by protein. The diets were 104 
similar in ER, which allowed us to study potential additional effects of protein 105 
quantity over ER on gene expression changes in subcutaneous WAT.  106 
 107 
MATERIALS AND METHODS  108 
Study design 109 
The current study was part of a previously published double-blind randomized 110 
study21. Power calculation has been described in the original study21 and was 111 
based on the primary outcome lean body mass (LBM). Subjects were excluded if 112 
they suffered from renal insufficiency (MDRD estimated glomerular filtration rate 113 
>60 mL/min per 1.73 m2), type 1 or type 2 diabetes (fasting glucose levels ⩾7 114 
mmol/L), cancer, chronic obstructive pulmonary disease, allergy to milk products 115 
or underwent a gastric bypass. Subjects were also excluded if they had severe 116 
loss of appetite, participated in a weight loss or heavy resistance-type exercise 117 
program three months before the intervention or if they used supplements or 118 
drugs known to interfere with energy balance. Women could only participate if 119 
they were postmenopausal (last period 1 year previous to study start). 120 
Randomization was carried out with permuted blocks, stratified by gender and 121 
BMI. This intervention study was highly controlled, as 90% of the daily energy 122 
intake was provided by the University. Sixty-one overweight and obese healthy 123 
women (n=25) and men (n=36), aged 55-70 years, were randomly assigned to 124 
either a high-protein diet (HP-ER; 1.7 g protein/kg per day) or normal protein 125 
diet (NP-ER; 0.9 g protein/kg per day), during a 12-week 25% energy intake 126 
restriction. A subcutaneous adipose tissue biopsy was taken before and after the 127 
intervention from 22 participants. The study protocol was approved by the 128 
Medical Ethical Committee of Wageningen University and written informed 129 
consent was obtained before study participation. The study was registered at 130 
clinicaltrials.gov as NCT01915030. 131 
Adipose tissue biopsy 132 
Abdominal subcutaneous white adipose tissue biopsies (~1 g) were collected by 133 
needle biopsy, 6 to 8 cm lateral from the umbilicus under local anaesthesia (2% 134 
lidocaine) in 22 fasted participants. For each person, the second biopsy upon the 135 
intervention was taken on the contralateral side opposite to the first biopsy taken 136 
before the intervention. After immediate washing with PBS, the tissue was snap-137 
frozen in liquid nitrogen and stored at -80°C until analysis. 138 
RNA isolation and microarray processing 139 
Total RNA was extracted from frozen adipose tissue specimens using TRIzol 140 
reagent (Invitrogen, Breda, The Netherlands) and purified on columns using the 141 
Qiagen RNeasy Micro Kit (Qiagen, Venlo, The Netherlands). RNA integrity was 142 
checked with Agilent 2100 bioanalyzer (Agilent Technologies, Amstelveen, The 143 
Netherlands). Total RNA (500 ng/sample) was labelled using a one-cycle cDNA 144 
labelling kit (MessageAmpTM II-Biotin Enhanced Kit; Ambion Inc, Nieuwekerk 145 
aan de IJssel, The Netherlands). Sample labelling, hybridization to chips, and 146 
image scanning were performed according to the manufacturer’s instructions. 147 
Total RNA (100 ng per sample) was labelled by Whole-Transcript Sense Target 148 
Assay and hybridized to human whole-genome Affymetrix® Human Gene 1.1 ST 149 
arrays targeting 19715 unique genes (Affymetrix, Santa Clara, CA, USA).  150 
Microarray data analysis 151 
Microarray quality control and normalization were performed using Bioconductor 152 
software packages integrated in an on-line pipeline called MADMAX22. Microarray 153 
signals were normalized using robust multichip average (RMA)23. Genes with 154 
normalized signals >20 on at least 6 arrays were defined as expressed and 155 
selected for further analysis. Significant different expression of individual genes 156 
were tested using the LIMMA R library24. Changes were considered significant 157 
when p-value was <0.05 in a paired t-test with Bayesian correction. Data were 158 
further analysed with gene set enrichment analysis (GSEA) using pre-ranked lists 159 
based on the t-statistic25. Gene sets with a false discovery rate (FDR-q-value) 160 
<0.25 were defined as significantly regulated. A transcription factor analysis was 161 
performed on the differentially expressed genes (P-value <0.05) with Ingenuity 162 
Pathway Analysis (June 2012, Ingenuity Systems, Redwood City, CA, USA). 163 
Array data have been submitted to the Gene Expression Omnibus under 164 
accession number GSE84046. 165 
Statistical Analysis of clinical measurements 166 
Data is presented as mean ± standard deviation (SD). To check if there were 167 
baseline differences between the groups, an independent sample t-test was 168 
used. A paired t-test was used to check if parameters changed within groups 169 
over time. An unpaired t-test was used to check if changes in parameters were 170 
significant different between groups. Data were analyzed using SPSS version 22 171 
(SPSS Inc. Chicago, IL). Results were considered statistically significant below 172 
the 0.05 level.    173 
RESULTS 174 
Baseline characteristics of the 22 participants volunteering a white adipose tissue 175 
biopsy are summarised in table 1. None of the participant characteristics differed 176 
between the two intervention groups (P>0.05).   177 
The effect of 12 weeks of 25% ER is seen in the decrease of 9.4 kg (±3.2) body 178 
weight on average in all participants. HP-ER and NP-ER both resulted in a 179 
decrease in body weight and BMI in both groups (supplementary table 1). Protein 180 
quantity of the diets had no effect on weight (P=0.45) or BMI change (P=0.52). 181 
 182 
Effect of ER on gene expression: up- and downregulation 183 
To identify the effect of 25% ER on whole genome gene expression in adipose 184 
tissue, we first analysed the two ER intervention groups as one group. A total of 185 
1858 genes showed a significant change in expression upon 12 weeks 25% ER 186 
(supplementary figure 1).   187 
To identify potential pathways and signalling routes, Gene Set Enrichment 188 
Analysis (GSEA) was performed. A total of 353 gene sets was enriched upon ER 189 
(supplementary table 2) of which 72 up- and 281 downregulated. To merge 190 
overlapping and similar pathways, gene sets were clustered using Cytoscape. 191 
Clusters of gene sets are summarized in table 2. Clusters of gene sets involved in 192 
energy metabolism, such as lipid metabolism and PPARα targets, NRF2 targets, 193 
glucose metabolism, and TCA cycle, as well as gene sets in oxidative 194 
phosphorylation, adaptive immune response, immune cell infiltration, and cell 195 
cycle were decreased. RNA translation and processing-related gene sets were 196 
increased. 197 
 198 
As  energy metabolism-related pathways turned out to be quite prominently 199 
regulated, we visualized the robustness of the ER-induced individual changes in 200 
expression of genes related to energy metabolism by creating a heatmap, 201 
showing gene expression changes per gene per individual (figure 1). Three out of 202 
22 participants had a different pattern in their gene expression profiles. To 203 
evaluate whether these differences in response were due to weight loss 204 
differences, BMI/weight loss change was also plotted, below this heatmap. 205 
Weight loss or BMI change did no show consistent change with responders or 206 
non-responder profile changes. To further analyse whether correlations were 207 
present between the gene expression changes and between weight and BMI 208 
change, we created a correlation heatmap (supplementary figure 2). Correlations 209 
were observed between most genes related to energy metabolism, with the 210 
strongest correlation between expression changes of genes involved in lipid 211 
metabolism. Not many correlations were observed between gene expression 212 
changes and weight or BMI change. To visualize the genes involved in energy 213 
metabolism of which the expression was changed upon ER a schematic adipocyte 214 
was created (figure 2).  215 
 216 
Effect of ER on gene expression: IPA Upstream Regulator analysis  217 
To identify potential upstream transcriptional regulators of genes of which 218 
expression changed upon 25% ER, IPA Upstream Regulator Analysis was used 219 
(supplementary table 3ab). Many upstream regulators known to control lipid 220 
metabolism were significantly predicted to be inhibited and included peroxisome 221 
proliferator-activated receptor gamma (PPARG: z=-3.491, P=8.14E-12) and 222 
sterol regulatory element-binding proteins 1 and 2 (SREBF1: z=-3.683, P=3.33E-223 
06; SREBF2: z=-3.478, P=7.41E-07). These findings fit with the strong 224 
correlation between changes in expression of their lipid-related target genes 225 
upon 25% ER (supplementary figure 2). Peroxisome proliferator-activated 226 
receptor gamma coactivator 1-alpha (PGC-1α), known to regulate oxidative 227 
phosphorylation, was predicted to be inhibited as well.   228 
 229 
Protein quantity 230 
Effect of protein quantity on gene expression during ER 231 
To identify the effect of a carbohydrate-for-protein exchange in addition to ER on 232 
molecular level, we compared gene expression changes upon HP-ER with gene 233 
expression changes upon NP-ER. Flowchart of selection of genes is shown in 234 
figure 3. HP-ER resulted in a significant different expression of 1869 genes and 235 
NP-ER resulted in a significant different expression of 1690 genes. A number 530 236 
genes showed a significantly different expression change  between the HP-ER 237 
and NP-ER and 500 genes showed an overlap between both diets. 238 
 239 
Effect of ER and protein quantity on gene expression: pathway analysis 240 
To identify in what pathways and signalling routes these genes were involved, 241 
GSEA was performed. A total of 371 gene sets were enriched in the NP-ER group, 242 
of which 46 up- and 325 downregulated. A total of 241 gene sets were enriched 243 
in the HP-ER group, of which 69 up- and 172 downregulated (supplementary 244 
table 4a-d). Comparing the response of the two diets, a number of 123 gene sets 245 
showed a significant difference between the two groups (supplementary table 5). 246 
Gene sets were clustered using Cytoscape as described above. A summary of the 247 
identified clusters with a differential change between the diets and a significant 248 
change upon at least one of the diets, is provided in table 3. NP-ER diet showed 249 
a downregulation of pathways involved in inflammasome, adaptive immune 250 
response, immune cell infiltration, and cell cycle, while HP-ER diet did not result 251 
in a downregulation of inflammatory pathways and resulted in an upregulation of 252 
cell cycle and GPCR-signalling, olfactory, and nitrogen metabolism-related 253 
pathways.  254 
To visualize the individual changes in expression of genes that belonged to the 255 
downregulated clusters of pathways, we selected the genes from these clusters: 256 
immune cell infiltration, inflammasome, adaptive immune response and cell 257 
cycle. Genes with a significant different expression (P-value <0.05) between the 258 
HP-ER and NP-ER diet and a significant change in expression in either the HP-ER 259 
or the NP-ER diet group, were incorporated in a heatmap (supplementary figure 260 
3a). To identify potential correlations between those genes, a correlation 261 
heatmap was made (supplementary figure 3b). Positive correlations were 262 
observed for genes involved in immune cell infiltration and cell cycle, as is seen 263 
by the purple triangles.  264 
 265 
Effect of protein quantity on gene expression: IPA Upstream Regulator 266 
analysis  267 
IPA Upstream Regulator Analysis was used to identify potential upstream 268 
transcriptional regulators of genes significantly different expressed between HP-269 
ER and NP-ER diet. Only 26S proteasome was predicted to be upregulated 270 
comparing the two groups, but was not predicted to be significantly upregulated 271 
or inhibited within the HP-ER group or in the NP-ER group.  272 
  273 
DISCUSSION   274 
Within this study we aimed to investigate the effect of a change in protein 275 
quantity in an ER diet on the regulation of pathways and signalling routes in 276 
human white adipose tissue. Although parameters such as weight loss, glucose, 277 
and waist circumference did not change due to altered protein quantity in the 278 
25% ER diet, whole genome adipose tissue gene expression did change due to 279 
the difference in protein quantity. Only the normal protein ER diet (NP-ER), and 280 
not the high protein ER diet (HP-ER), resulted in a downregulation of expression 281 
of genes involved in inflammasome, immune cell infiltration, adaptive immune 282 
response, and cell cycle-related pathways in human adipose tissue. To the best 283 
of our knowledge, no studies are known that explored the effect of an exchange 284 
of protein for carbohydrates in ER diets on whole genome gene expression in 285 
human adipose tissue. Only one study could be identified that compared the 286 
effect of a high-protein, low glycaemic index and soluble fibre ER diet with a 287 
standard ER diet on white adipose tissue whole-genome gene expression, but 288 
this study showed no significant differences between the two diets. Changes in 289 
gene expression were only observed if both ER groups were combined26. This is 290 
partly in line with findings in our study, in which more changes in gene 291 
expression due to ER than due to protein quantity were observed. However, in 292 
contrast to the above mentioned study, we could define a clear nutrient-specific 293 
set of genes that were either more affected upon HP-ER or more affected in the 294 
NP-ER. This deviation in outcomes can be due to differences in study design. In 295 
the before mentioned study 13 persons were included, while we had a larger 296 
number of 22 participants. In our study, diets were followed for a period of 12 297 
weeks, in contrast to only 4 weeks, which could account for a more persisting 298 
effect of the diets on gene expression. Furthermore, the cross-over design had a 299 
washout period of 8 weeks between both ER diets. This period might have been 300 
too short for adipocytes to recover from ER and may have caused a carryover-301 
effect on gene expression. 302 
The observed reduction in expression of genes involved in immune response 303 
pathways and inflammasome-related pathways upon a normal protein diet which 304 
was not observed on a high-protein diet, is interesting with respect to their role 305 
in inflammation in adipose tissue. Adipose tissue in obese individuals is 306 
characterized by increased expression of genes involved in the inflammasome 307 
and immune response27 28. Several studies have observed that caloric restriction 308 
or exercise-mediated weight-loss resulted in a reduced expression of these 309 
genes29. Interestingly, we only observed those effects for the normal protein 310 
diet. When the protein quantity of the ER diet increased, the beneficial effects on 311 
inflammation–related gene expression were not observed. This observation 312 
points towards the potential importance of dietary macronutrient composition 313 
during ER on adipose tissue health. Despite the findings of macronutrient-specific 314 
effects, the impact of ER on gene expression was much greater. Moreover, 315 
strong correlations between changes in gene expression were observed, 316 
suggesting a potential upstream regulator responsible for this accurate regulation 317 
in expression. Especially a strong correlation between changes in expression of 318 
lipid-related genes upon ER was found. In line with this, upstream regulators 319 
PPARG and SREBPs, strong regulators of lipid metabolism, were predicted to be 320 
inhibited. Furthermore, oxidative phosphorylation related-pathways were 321 
downregulated upon ER, which is in line with the finding that PGC-1α was 322 
predicted to be inhibited. In addition to the pathway analysis, which identified 323 
only downregulated pathways related to energy metabolism upon ER, expression 324 
of several genes were found to be upregulated upon CR that were related to 325 
energy metabolism pathways as well. For example, phosphoenolpyruvate 326 
carboxykinase 2 (PCK2) and pyruvate dehydrogenase kinase 4 (PDK4) were 327 
upregulated. PCK2 catalyses the rate-limiting step in gluconeogenesis, when 328 
glucose is formed from lactate and other precursors derived from the TCA-cycle. 329 
Upregulation of PCK2 could be due to shortage of glucose intake and the 330 
subsequent increased need of glucose formation from different precursors. PDK4 331 
is a key inhibitor in glucose metabolism30 and its upregulation may be explained 332 
by a decreased need for glucose oxidation. PDK4 gene expression is also known 333 
to be upregulated in human PBMCs upon fasting31. Genes involved in lipid 334 
metabolism were also upregulated. For example angiopoietin-like 4 (ANGPTL4), 335 
an inhibitor of lipoprotein lipase (LPL), was upregulated and in line with this LPL 336 
was downregulated. This inhibition of LPL during ER can be explained by the 337 
assumption that fat storage is not of primary importance during ER. Also cell 338 
death activator (CIDEA), important for lipolysis, was upregulated upon ER which 339 
can be explained by a higher demand for stored lipids as energy source. PCK2, 340 
PDK4, ANGPTL4, and CIDEA are all well-known PPAR targets pointing to two kind 341 
of effects on PPAR-target-genes, either up- or downregulation, depending on 342 
their functional role in adipose tissue during ER. 343 
One problem in changing one macronutrient in a diet is the consequential change 344 
of another macronutrient. In our study, protein was exchanged for 345 
carbohydrates. The effects could therefore also be due to the higher amount of 346 
carbohydrates in the NP-ER diet, or due to  the lower amount of carbohydrates in 347 
the HP-ER diet. Especially the downregulation observed in glucose metabolism 348 
may be related to the decrease in carbohydrate quantity. One clear finding that 349 
has also been found in other transcriptome studies is the variation in response. 350 
In three out of 22 participants we observed a different gene expression response 351 
upon ER. We could not explain this variation by the amount of weight loss or 352 
weight gain. Genetic background could be important in explaining some of the 353 
variation in gene expression, as was shown before32, but sample sizes within this 354 
study were too small to adequately measure such effects. 355 
A strength of our study is the highly controlled food intake. Participants were 356 
provided with all meals and always consumed their hot meal at the University, 357 
leading to a high compliance. Furthermore, effects of participants’ habitual diets 358 
were largely ruled out before the start of the intervention due to one week of 359 
standardised meals for the participants. However, the number of adipose 360 
biopsies was small: 10 and 12 participants per intervention arm. The aim of this 361 
study was explorative and therefore an FDR q-value of <0.25 was selected. 362 
However, examining the data with an FDR q-value of <0.1 resulted in the same 363 
clusters of gene sets and conclusion. Although findings are quite robust and 364 
provide some interesting leads, care should be taken in interpretation and 365 
translation of the findings, since results have not yet been replicated 366 
independently. Protein quantity has been studied to investigate its effect on 367 
health parameters related to muscle mass but findings show discrepancies 21. As 368 
our findings are based on adipose tissue gene expression, caution should be 369 
taken when translating this to health advice. Further studies are needed that 370 
explore our findings in a larger population.  371 
In conclusion, 25% ER induces a decrease in lipid and energy metabolism-related 372 
pathways, likely partly regulated via PPARG and PGC1α, in white adipose tissue 373 
in humans. The consumption of normal protein quantity compared to a high 374 
protein quantity during ER has a more beneficial effect on inflammation-related 375 
gene expression in adipose tissue, as reflected by a decrease in inflammasome 376 
and adaptive immunity response-related pathways.  377 
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FIGURE LEGEND  533 
Figure 1. Heatmap of individual gene expression changes upon 25%  ER of 534 
genes involved in energy metabolism. Each column represents the signal log 535 
ratio of one person; each row represents one gene. 536 
Legend: 537 
Colours in heatmap:  538 
Blue = downregulated, Orange = upregulated;  539 
Red: genes in Oxidative phosphorylation;  540 
Green: genes in NRF2 targets;  541 
Purple: genes in Lipid metabolism;  542 
Pink: genes in TCA cycle; 543 
Light blue: genes in Glucose metabolism. 544 
 545 
Figure 2. Schematic visualisation of adipocyte with up- or downregulated 546 
expression of genes involved in energy metabolism that changed upon 25% ER.  547 
 548 
Figure 3. Stepwise selection of genes  for microarray analysis: first, genes were 549 
selected for their signal intensity (≥20 in >6 arrays), and second, for a change in 550 
expression upon either normal protein energy restriction (NP-ER) diet, or upon 551 
high protein energy restriction (HP-ER) diet (P<0.05). The last block shows the 552 
number of genes that have a significantly different change in expression between 553 
HP-ER and NP-ER.   554 
  555 
TABLES 556 
Table 1. Baseline characteristics of participants included in the microarray 557 
analysis of adipose tissue biopsies.  558 
Legend belonging to table 1: Data represent mean and (SD), or median and 559 
[range]. HP-ER: High protein-energy restriction; NP-ER: Normal protein-energy 560 
restriction; ♂: men; ♀: women. 561 
Table 2. Summary of changes in main clusters of pathways in white adipose 562 
tissue of the total study population upon 12 weeks of 25% energy restriction 563 
(supplementary table 1). 564 
Legend belonging to table 2: Significantly changed pathways are determined with 565 
GSEA and clusters are based upon Cytoscape ↑: gene sets in this pathway-cluster 566 
were upregulated; ↓: gene sets in this pathway-cluster were downregulated. 567 
1Selection of these clusters based on: gene sets with a significantly different 568 
response between HP-ER and NP-ER, and significantly changed upon HP-ER (left) 569 
or NP-ER (right). 570 
Table 3. Summary of changes in main clusters of pathways in white adipose 571 
tissue upon 12 weeks of 25% energy restriction with either high protein (HP-ER) 572 
or normal protein (NP-ER). 573 
Legend belonging to table 3: Significantly changed pathways are determined with 574 
GSEA and clusters are based upon Cytoscape ↑: gene sets in this pathway-cluster 575 
were upregulated; ↓: gene sets in this pathway-cluster were downregulated; - 576 
pathway cluster was not changed. 1Selection of these clusters based on: gene 577 
sets with a significantly different response between HP-ER and NP-ER, and 578 
significantly changed upon HP-ER (left) or NP-ER (right). 579 
Table 1. Baseline characteristics of participants included in the microarray 
analysis of adipose tissue biopsies.  
Data represent mean and (SD), or median and [range]. HP-ER: High protein-
energy restriction; NP-ER: Normal protein-energy restriction; ♂: men; ♀: women. 
 
 HP-ER 
n=12 
NP-ER 
n=10 
Age (y) 62.3 [56, 69] 61.6 [57, 68] 
Gender 8♂ / 4♀ 7♂ / 3♀ 
Height (m) 1.72 (0.11) 1.74 (0.068) 
Weight (kg) 93.2 (10.2) 91.9 (6.1) 
Body mass index (kg/m2) 31 (3) 30 (2) 
Glucose (mmol/L) 6.0 (0.59) 5.9 (0.54) 
Waist circumference (cm) 110 (9.30) 110 (6.41) 
Table 2. Summary of changes in main clusters of pathways in white adipose 
tissue of the total study population upon 12 weeks of 25% energy restriction 
(supplementary table 1).  
Significantly changed pathways are determined with GSEA and clusters are 
based upon Cytoscape ↑: gene sets in this pathway-cluster were upregulated; ↓: 
gene sets in this pathway-cluster were downregulated. 
1Selection of these clusters based on: gene sets with a significantly different 
response between HP-ER and NP-ER, and significantly changed upon HP-ER (left) 
or NP-ER (right). 
 
 
Pathway cluster1 25% ER (n = 22) 
Lipid metabolism and PPARα targets ↓
NRF2 targets ↓
Glucose metabolism ↓
TCA cycle ↓
Oxidative phosphorylation ↓
Adaptive immune response ↓ 
Immune cell infiltration ↓ 
Cell cycle ↓ 
RNA translation and processing ↑ 
Table 3. Summary of changes in main clusters of pathways in white adipose 
tissue upon 12 weeks of 25% energy restriction with either high protein (HP-ER) 
or normal protein (NP-ER). 
Significantly changed pathways are determined with GSEA and clusters are 
based upon Cytoscape ↑: gene sets in this pathway-cluster were upregulated; ↓: 
gene sets in this pathway-cluster were downregulated; - pathway cluster was not 
changed. 
1Selection of these clusters based on: gene sets with a significantly different 
response between HP-ER and NP-ER, and significantly changed upon HP-ER (left) 
or NP-ER (right). 
 
Pathway cluster1 
HP-ER 
(n = 12) 
NP-ER 
(n = 10) 
Immune cell infiltration - ↓ 
Inflammasome - ↓
Adaptive immune response - ↓
Cell cycle -/↑ ↓ 
GPCR Signalling 
 Including olfactory signalling 
-/↑ 
↑ 
↓ 
- 
Nitrogen metabolism ↑ - 
-0.1 0.10.0
-0.5 0.50.0


